Vivlodex
NDC Package 42211-206-41

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Vivlodex is meloxicam is used to treat arthritis. Marketed by Iroko Pharmaceuticals, Llc, this product is identified by NDC 42211-206 and is authorized under FDA application NDA207233.

Identification & Billing

NDC Package Code
42211-206-41
Package Description
1 CAPSULE in 1 BLISTER PACK
Product Code
42211-206
11-Digit Billing Format
42211020641
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Vivlodex
Dosage Form
-
Usage Information
Meloxicam is used to treat arthritis. It reduces pain, swelling, and stiffness of the joints. Meloxicam is known as a nonsteroidal anti-inflammatory drug (NSAID). If you are treating a chronic condition such as arthritis, ask your doctor about non-drug treatments and/or using other medications to treat your pain. See also Warning section.

Regulatory & Marketing

Labeler Name
Iroko Pharmaceuticals, Llc
FDA Application #
NDA207233
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
10-31-2015
Listing Expiration
12-31-2020
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (42211-206). Click a package code to view its specific billing and regulatory data.

42211-206-23
30 CAPSULE in 1 BOTTLE
42211-206-29
90 CAPSULE in 1 BOTTLE

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 42211-206-41 identifies a specific commercial package of 1 capsule in 1 blister pack of Vivlodex, labeled by Iroko Pharmaceuticals, Llc. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Iroko Pharmaceuticals, Llc on October 31, 2015. The current certification is valid through December 31, 2020.

What are the primary indications for this medication?

Meloxicam is used to treat arthritis. It reduces pain, swelling, and stiffness of the joints. Meloxicam is known as a nonsteroidal anti-inflammatory drug (NSAID). If you are treating a chronic condition such as arthritis, ask your doctor about non-drug treatments and/or using other medications to treat your pain. See also Warning section.

How is this Iroko Pharmaceuticals, Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 42211020641. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
42211-206-41
11-Digit CMS (5-4-2)
42211-0206-41

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.